Cargando…

Advances in the relationship between coronavirus infection and cardiovascular diseases

The outbreak of coronavirus disease 2019 (COVID-19) has once again aroused people's concern about coronavirus. Seven human coronaviruses (HCoVs) have been discovered so far, including HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU115, severe acute respiratory syndrome coronavirus, Middle East respir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Mengmeng, Wang, Menglong, Zhang, Jishou, Ye, Jing, Xu, Yao, Wang, Zhen, Ye, Di, Liu, Jianfang, Wan, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Masson SAS. 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218375/ https://www.ncbi.nlm.nih.gov/pubmed/32428835 http://dx.doi.org/10.1016/j.biopha.2020.110230

Ejemplares similares

Recent progress of antiviral therapy for coronavirus disease 2019
por: Zhao, Mengmeng, et al.
Publicado: (2021)

The Anti-inflammatory Mediator Resolvin E1 Protects Mice Against Lipopolysaccharide-Induced Heart Injury
por: Zhang, Jishou, et al.
Publicado: (2020)

The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022)

The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges
por: Wang, Zhen, et al.
Publicado: (2019)

Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress
por: Wang, Menglong, et al.
Publicado: (2022)

The Association between Obesity and Severity in Patients with Coronavirus Disease 2019: a Retrospective, Single-center Study, Wuhan
por: Zhang, Jishou, et al.
Publicado: (2021)

The expression of interleukin-25 increases in human coronary artery disease and is associated with the severity of coronary stenosis
por: Xu, Yao, et al.
Publicado: (2020)

Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages
por: Zhao, Mengmeng, et al.
Publicado: (2020)

Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study
por: Wang, Zhen, et al.
Publicado: (2020)

ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease
por: Wang, Zhen, et al.
Publicado: (2019)

Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice
por: Ye, Jing, et al.
Publicado: (2020)

The Role of Interleukin-6 Family Members in Cardiovascular Diseases
por: Feng, Yongqi, et al.
Publicado: (2022)

The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Wang, Menglong, et al.
Publicado: (2023)

The Clinical Characteristics and Prognosis Factors of Mild-Moderate Patients With COVID-19 in a Mobile Cabin Hospital: A Retrospective, Single-Center Study
por: Zhang, Jishou, et al.
Publicado: (2020)

Il12a Deletion Aggravates Sepsis-Induced Cardiac Dysfunction by Regulating Macrophage Polarization
por: Wang, Zhen, et al.
Publicado: (2021)

MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice
por: Wang, Menglong, et al.
Publicado: (2022)

Decreased Low-Density Lipoprotein Cholesterol Level Indicates Poor Prognosis of Severe and Critical COVID-19 Patients: A Retrospective, Single-Center Study
por: Zhao, Mengmeng, et al.
Publicado: (2021)

Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
por: Ye, Jing, et al.
Publicado: (2020)

Time-dependent changes in the clinical characteristics and prognosis of hospitalized COVID-19 patients in Wuhan, China: A retrospective study
por: Wang, Menglong, et al.
Publicado: (2020)

Scavenger Receptors in Myocardial Infarction and Ischemia/Reperfusion Injury: The Potential for Disease Evaluation and Therapy
por: Zhang, Jishou, et al.
Publicado: (2023)

Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases
por: Wang, Menglong, et al.
Publicado: (2022)

Inhibition of TRPA1 Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Suppressing Oxidative Stress, the Inflammatory Response, and Endoplasmic Reticulum Stress
por: Wang, Zhen, et al.
Publicado: (2018)

Corrigendum to “TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice” [EBioMedicine (2018) 54–62]
por: Wang, Zhen, et al.
Publicado: (2018)

TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
por: Wang, Zhen, et al.
Publicado: (2018)

Microglia‐Mediated Neuroimmune Response Regulates Cardiac Remodeling After Myocardial Infarction
por: Wang, Menglong, et al.
Publicado: (2023)

Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
por: Ye, Jing, et al.
Publicado: (2020)

IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice
por: Liu, Menglin, et al.
Publicado: (2022)

IL-30 protects against sepsis-induced myocardial dysfunction by inhibiting pro-inflammatory macrophage polarization and pyroptosis
por: Zhao, Mengmeng, et al.
Publicado: (2023)

The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis
por: Ye, Jing, et al.
Publicado: (2020)

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future
por: Zhang, Jishou, et al.
Publicado: (2020)

Advances in the relationship between coronavirus infection and coagulation function
por: Zou, Hai, et al.
Publicado: (2020)

Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
por: Zhao, Mengmeng, et al.
Publicado: (2022)

Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
por: Ye, Jing, et al.
Publicado: (2019)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019)

The clinical potential of IL-12/IL-35 in treating chemotherapy drug-induced cardiac injury – Authors' reply
por: Ye, Jing, et al.
Publicado: (2018)

Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice
por: Ye, Jing, et al.
Publicado: (2018)

Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II–Treated Mice
por: Ye, Jing, et al.
Publicado: (2017)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b08tfmc570itlf07bsnmgo0450